A Multicenter Randomized Study in Early Rheumatoid Arthritis to Compare Active Conventional Therapy versus Three Biological Treatments: 24 Week Efficacy and Safety Results of the NORD-STAR Trial

Merete Lund Hetland, Espen A. Haavardsholm, Anna Rudin, Dan Nordstrom, Mike Nurmohamed, Bjorn Gudbjornsson, Jon Lampa, Kim Horslev-Petersen, Till Uhlig, Gerdur Grondal, Mikkel Ostergaard, Marte Heiberg, Jos Twisk, Kristina Lend, Simon Krabbe, Joakim Lindqvist, Anna-Karin Ekwall, Kathrine Lederballe Gron, Meliha Kapetanovic, Francesca FaustiniRiitta Tuompo, Tove Lorenzen, Giovanni Cagnotto, Eva Baecklund, Oliver Hendricks, Daisy Vedder, Tuulikki Sokka-isler, Tomas Husmark, Maud-Kristine Aga Ljosa, Eli Brodin, Torkell Ellingsen, Annika Soderbergh, Milad Rizk, Asa Reckner, Line Uhrenholt, Per Larsson, Soeren Just, David Stevens, Trine Laurberg, Gunnstein Bakland, Inge Christoffer Olsen, Ronald van Vollenhoven, NORD-STAR Study Group

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberL09
JournalArthritis & Rheumatology
Volume71
Issue numberSuppl. 10
Number of pages1
ISSN2326-5191
Publication statusPublished - Oct 2019
Event2019 ACR/ARP Annual Meeting - Atlanta, United States
Duration: 8. Nov 201913. Nov 2019

Conference

Conference2019 ACR/ARP Annual Meeting
Country/TerritoryUnited States
CityAtlanta
Period08/11/201913/11/2019

Cite this